Dr Gisa Gerold, PhD
Gisa Gerold graduated with a Diploma in Biochemistry, Physical Chemistry and Microbiology from the Eberhard Karls Universität Tübingen, Germany. She received her Ph.D. in Biology and Biochemistry in the laboratory of Professor Arturo Zychlinsky at the Max Planck Institute for Infection Biology in Berlin, Germany in 2008. During her doctoral studies she investigated the sensing of bacteria by the innate immune system. This work was awarded the Otto Hahn Medal of the Max Planck Society.
In 2009 Gisa moved to the Center for the Study of Hepatitis C at the Rockefeller University, New York, where she investigated various aspects of Hepatitis C virus (HCV) infection, among others the species tropism of HCV and HCV-related animal viruses. She received stipends from the German Academy of Sciences Leopoldina and the Human Frontier Science Foundation for her stay in the United States. Her postdoctoral work was awarded the Robert Koch Postdoctoral prize in Virology.
Since February 2012, Gisa has been working at the TWINCORE in Hannover, Germany where she analyses the mechanistic details of HCV entry into hepatocytes using proteomics and virology techniques. Since 2017 she has been head of the research group "Virus interaction proteomics" at TWINCORE. In 2018 she was appointed a Guest Associate Professor at the Wallenberg Center for Molecular Medicine of Umea University, Sweden. Her German and Swedish team focuses on how human pathogenic viruses such as HCV and Chikungunya virus gain access into human cells and how the innate immune system fights virus invasion. Using cutting edge technologies her group strives to uncover basic principles of virus entry and cellular sensing of incoming viruses.